Ask Warren

Easy Bio

353810 · KOSDAQ · ₩353810 · 이지바이오

₩5,350▼ ₩50 (0.93%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩148B₩131B₩129B₩117B₩114B₩117B₩118B₩106B
Cost of sales₩110B₩96B₩94B₩87B₩85B₩90B₩95B₩77B
Gross profit₩38B₩35B₩36B₩30B₩28B₩27B₩23B₩29B
Operating income₩15B₩13B₩14B₩11B₩11B₩9.1B₩8.7B₩8.9B
Net income−₩814M₩12B₩21B₩4.5B−₩1.7B₩5.8B₩14B₩2B
Net income to shareholders₩10B₩11B₩10B₩8.3B₩3.8B₩5.6B₩4.4B₩6.2B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩386B₩362B₩327B₩326B₩301B₩312B₩360B₩317B
Current assets₩215B₩194B₩189B₩190B₩169B₩168B₩219B₩193B
Cash and equivalents₩48B₩45B₩60B₩39B₩28B₩35B₩60B₩35B
Total liabilities₩254B₩242B₩214B₩225B₩213B₩224B₩271B₩245B
Current liabilities₩174B₩158B₩140B₩129B₩125B₩128B₩128B₩106B
Borrowings₩175B₩162B₩152B₩142B₩147B₩134B₩189B₩180B
Total equity₩132B₩120B₩114B₩100B₩89B₩88B₩89B₩72B
Shareholders' equity₩127B₩115B₩107B₩95B₩83B₩83B₩84B₩68B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩13B−₩1.1B₩20B₩13B₩3.1B−₩1.5B₩14B₩5.3B
Capital spending₩3B₩1.9B₩2.8B₩1.6B₩1.3B₩256M₩122M₩1.1B
Free cash flow₩9.9B−₩3.1B₩17B₩12B₩1.8B−₩1.8B₩14B₩4.2B
Dividends paid₩8.3B₩202M₩0₩71M₩0₩6.6B₩0₩0

Consolidated where available. Amounts in won.

Also known as: Easy Bio / 이지바이오 / 353810 / KRX:353810

Source: KRX statistical information